The Power List 2022 focuses on the top 10 VIPs in three key categories of medicine making
11/24/2022 | Stephanie Sutton | 4 min read
Widely-used antimalarial drugs are losing efficacy. What are researchers doing to prevent that?
11/10/2022 | Maryam Mahdi | 2 min read
Cryopreservation should maintain the viability of organs and cell therapies, but the process is riddled with challenges.
10/21/2022 | Stephanie Sutton | 10 min read
The remarkable story of gene therapy drug development during the 1990s and early 2000s.
10/17/2022 | Maryam Mahdi | 5 min read
Pharma must ask itself how it will contribute to the fight against women’s mental health challenges.
10/03/2022 | Maryam Mahdi | 2 min read
AI’s role in pharma operations and process is growing. But does it have the power to transform the industry?
08/23/2022 | Angus Stewart | 8 min read
The cell cycle can be used to shut down cancer’s survival mechanisms, but what does it take to turn that knowledge into a medicine?
07/27/2022 | Stephanie Sutton | 8 min read
We speak with Daniel Hornburg from Seer, a biotech company analyzing the proteomes of astronauts.
04/25/2022 | Stephanie Sutton
What will drug development look like aboard a new commercial space station?
02/17/2022
How work on sharks could provide a highly effective weapon against new COVID variants
12/01/2021 | Maryam Mahdi
Exploring the potential of vaccines for treatment equity.
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
The Grand Winner
How Data Sharing Can Upgrade AI for Pharma
Welcome to the CRISPR Powerhouse